Navigation Links
Verenium to Speak at the 2011 BIO World Congress on Industrial Biotechnology and Bioprocessing
Date:5/3/2011

SAN DIEGO, May 3, 2011 /PRNewswire/ -- Verenium Corporation (NASDAQ: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced that several members of management will speak at the 2011 BIO World Congress on Industrial Biotechnology and Bioprocessing.  The conference is taking place May 8-11, 2011 at the Toronto Convention Center.  

  • James Levine, President and Chief Executive Officer, will make opening remarks at a plenary breakfast, What Consumers and Manufacturers Need from Industrial Biotech Companies: A Customer Perspective on Tuesday, May 10th at 7:00 am.
  • Janet Roemer, Chief Operating Officer, will be moderating a panel, The Industrial Biotech Revolution, Has it Lived up to the Hype?, on Wednesday, May 11th at 11:00 am. Roemer will also be speaking on a panel, The Power of Enzymes, Tuesday, May 10th at 3:00 pm
  • Ken Barrett, Vice President, Business Development, will be moderating a panel, Protein Engineering and Screening Methods, Tuesday, May 10th at 9:00 am.
  • David Weiner, Ph.D., Vice President, R&D Strategy and Partnerships, will be speaking on a panel, The Industrial Biotech Revolution, Has it Lived up to the Hype?, Wednesday, May 11th at 11:00 am.

  • The Company will also have a booth at space 316 in the Toronto Convention Center.

    For more information on the BIO Industrial Biotechnology Conference please visit http://www.bio.org/worldcongress/index.asp

    About VereniumVerenium, an industrial biotechnology company, is a global leader in developing high-performance enzymes.  Verenium's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries, including the global food and fuel marke
    '/>"/>

    SOURCE Verenium Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
    2. Verenium Corporation to Present at the William Blair & Company 2008 Small-Cap Growth Stock Conference
    3. Verenium Corporation to Announce Third Quarter 2008 Financial Results
    4. Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference
    5. Verenium Regains Compliance With Nasdaq Continued Listing Requirement
    6. Verenium Announces First Commercial Cellulosic Ethanol Project
    7. Verenium Announces Organizational Changes
    8. Verenium Completes Amendment to 8% Senior Convertible Notes
    9. BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol
    10. Verenium Announces Reverse Stock Split to Take Effect September 9
    11. Verenium 1:12 Reverse Stock Split Takes Effect
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/29/2014)... in Iraq and Afghanistan, more than 300,000 soldiers have ... caused by exposure to bomb blasts and in ... of traumatic brain injury can range from the mild, ... impairments in memory and cognition. , Since 2007, ... importance and complexity of this problem, and has made ...
    (Date:9/29/2014)... food security, emerging diseases and biodiversity loss requires ... in Science Express that was co-authored ... College of Agriculture and Life Sciences. , For ... scientists has reviewed progress in addressing a broad ... management using approaches that consider evolutionary histories and ...
    (Date:9/29/2014)... (PRWEB) September 29, 2014 Transparency Market ... Synthesis - SPPS, LPPS, HPPS, by Application - Cancer, ... & Generic and by Delivery) - Global Industry Analysis, ... states that the global peptide therapeutics market was worth ... US$25.4 billion by 2018 at an 8.7% CAGR. , ...
    (Date:9/29/2014)... , Sept. 29, 2014 /PRNewswire/ - SQI Diagnostics Inc. ... develops and commercializes proprietary technologies and products for advanced ... Peter Winkley to Chairman of the Board ... Mr. Ricks will continue to serve as a Director ... to the Company.  "We are very ...
    Breaking Biology Technology:Modeling shockwaves through the brain 2Modeling shockwaves through the brain 3Modeling shockwaves through the brain 4Evolutionary biology: It's not just for textbooks anymore 2Evolutionary biology: It's not just for textbooks anymore 3Global Peptide Therapeutics Market to be Worth US$25.4 Billion by 2018: Transparency Market Research 2Global Peptide Therapeutics Market to be Worth US$25.4 Billion by 2018: Transparency Market Research 3SQI Diagnostics Announces New Chairman of Board of Directors 2
    ... by hiring laboratory reagent and diagnostics industry veteran , ... ... Inc., a high-tech provider of rapid prototyping and manufacturing services ... President of Operations. Dr. Anderson brings years of entrepreneurial and ...
    ... for November 6, 2008 at 10:00 a.m. EST, EAST ... ) today reported financial results for,the three and nine months ... of 2008 was $18.2 million or $0.34 per basic and ... net loss of $14.6,million or $0.28 per basic and diluted ...
    ... announced today the,submission of the response to the ... in Single Dose Containers). In an,Approvable Letter received ... with respect to chemistry, manufacturing, and controls (CMC)., ... complete response as a Class 2,resubmission, under which ...
    Cached Biology Technology:ALine, Inc. Expands Management, Adding Roger Anderson, Ph.D., as VP of Operations 2Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 2Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 3Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 4Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 5Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 6Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 7Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 8Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 9Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 10SALVAT Announces Submission of Complete Response to FDA Approvable Letter for CETRAXAL(R) 2
    (Date:9/29/2014)... 2014 Growing Demand From ... Increasing Security Concerns Continue to Propel Biometrics Market ... is one of the fastest growing biometrics ... systems, majorly in various government projects such as ... based biometrics dominates the country,s biometrics market, with ...
    (Date:9/29/2014)... release is available in French . ... - The number of days an expectant mother was ... the epigenetic profile of her child, a new study ... and McGill University have detected a distinctive ,signature, in ... the massive Quebec ice storm. Five months after the ...
    (Date:9/28/2014)... at the University of California, Santa Cruz, suggest that ... genomes of primates drove the evolution of complex regulatory ... cell of our bodies. , The arms race ... "jumping genes") and the genes that have evolved to ... the first time, identified genes in humans that make ...
    Breaking Biology News(10 mins):India Biometrics Market to Surpass USD2.7 Billion by 2019, Finds TechSci Research Study 2India Biometrics Market to Surpass USD2.7 Billion by 2019, Finds TechSci Research Study 3Human genome was shaped by an evolutionary arms race with itself 2Human genome was shaped by an evolutionary arms race with itself 3Human genome was shaped by an evolutionary arms race with itself 4
    ... to combat osteoporosis and other human common diseases is ... project "BlueGenics" which has received funding of EUR 6 ... team, coordinated by Professor Dr. Werner E.G. Mller from ... Medical Center, intends to identify and to utilize genetic ...
    ... believe that this knowledge may be important for the ... health issues, that modern science still hasn,t been able ... Center for Infectious Medicine at Karolinska Institutet and the ... time, it,s important to emphasize that humans have lived ...
    ... 2012 More than 100 academic institutions and ... initiative: Mathematics of Planet Earth (MPE) 2013. This ... mathematics in tackling global problems, including natural disasters ... sustainability; and pandemics. MPE2013 partners will sponsor workshops, ...
    Cached Biology News:Launch of the EU large-scale integrating project 'BlueGenics' to combat osteoporosis 2Launch of the EU large-scale integrating project 'BlueGenics' to combat osteoporosis 3How the common 'cat parasite' gets into the brain 2Mathematicians tackle global issues 2Mathematicians tackle global issues 3
    ... stain kits are optimized for use ... Dodeca stainers. This silver stain kit ... in polyacrylamide gels and are mass ... concentrate, silver reagent concentrate, background reducer ...
    ... This PTC-100 thermal cycler holds 96 x ... Hot Bonnet heated lid incorporates a thumbwheel ... seal PCR vessels for oil-free cycling. Peltier ... NIST-traceable calibration and ramping rates of up ...
    BioGenex IHC Kits for Rodent Tissues are designed for immunohistochemistry on rodent and rabbit tissues that are closely related to the source of the primary antibody. This kit comes with rat seconda...
    EZ-DeWax is a one-step solution that simultanously removes paraffin from and rehydrates formalin-fixed, paraffin embedded tissue...
    Biology Products: